Venus Concept (VERO) Competitors $2.39 -0.04 (-1.65%) Closing price 04:00 PM EasternExtended Trading$2.33 -0.06 (-2.72%) As of 07:46 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock VERO vs. PETV, BSGM, ICU, PAVM, BTCY, ALUR, SSKN, CODX, POAI, and NUROShould you be buying Venus Concept stock or one of its competitors? The main competitors of Venus Concept include PetVivo (PETV), BioSig Technologies (BSGM), SeaStar Medical (ICU), PAVmed (PAVM), Biotricity (BTCY), Allurion Technologies (ALUR), STRATA Skin Sciences (SSKN), Co-Diagnostics (CODX), Predictive Oncology (POAI), and NeuroMetrix (NURO). These companies are all part of the "medical equipment" industry. Venus Concept vs. PetVivo BioSig Technologies SeaStar Medical PAVmed Biotricity Allurion Technologies STRATA Skin Sciences Co-Diagnostics Predictive Oncology NeuroMetrix PetVivo (NASDAQ:PETV) and Venus Concept (NASDAQ:VERO) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, earnings, profitability, media sentiment, valuation, risk and community ranking. Which has more risk & volatility, PETV or VERO? PetVivo has a beta of 1.85, indicating that its stock price is 85% more volatile than the S&P 500. Comparatively, Venus Concept has a beta of 0.25, indicating that its stock price is 75% less volatile than the S&P 500. Is PETV or VERO more profitable? Venus Concept has a net margin of -74.62% compared to PetVivo's net margin of -902.82%. Venus Concept's return on equity of 0.00% beat PetVivo's return on equity.Company Net Margins Return on Equity Return on Assets PetVivo-902.82% -4,813.07% -281.78% Venus Concept -74.62%N/A -47.46% Which has better valuation & earnings, PETV or VERO? PetVivo has higher earnings, but lower revenue than Venus Concept. PetVivo is trading at a lower price-to-earnings ratio than Venus Concept, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioPetVivo$1.05M13.89-$10.95M-$0.45-1.33Venus Concept$64.83M0.05-$37.25M-$77.35-0.03 Do insiders & institutionals hold more shares of PETV or VERO? 24.5% of PetVivo shares are owned by institutional investors. Comparatively, 87.4% of Venus Concept shares are owned by institutional investors. 10.8% of PetVivo shares are owned by company insiders. Comparatively, 49.0% of Venus Concept shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock will outperform the market over the long term. Does the MarketBeat Community favor PETV or VERO? Venus Concept received 34 more outperform votes than PetVivo when rated by MarketBeat users. CompanyUnderperformOutperformPetVivoN/AN/AVenus ConceptOutperform Votes3465.38% Underperform Votes1834.62% Does the media prefer PETV or VERO? In the previous week, Venus Concept had 1 more articles in the media than PetVivo. MarketBeat recorded 2 mentions for Venus Concept and 1 mentions for PetVivo. Venus Concept's average media sentiment score of 0.43 beat PetVivo's score of 0.00 indicating that Venus Concept is being referred to more favorably in the news media. Company Overall Sentiment PetVivo Neutral Venus Concept Neutral SummaryVenus Concept beats PetVivo on 10 of the 14 factors compared between the two stocks. Get Venus Concept News Delivered to You Automatically Sign up to receive the latest news and ratings for VERO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart VERO vs. The Competition Export to ExcelMetricVenus ConceptSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$3.36M$4.34B$5.50B$7.96BDividend YieldN/A39.94%5.11%4.23%P/E Ratio-0.2930.6722.6318.55Price / Sales0.0555.17397.30103.38Price / CashN/A51.0838.1834.62Price / Book-0.976.056.704.25Net Income-$37.25M$68.71M$3.23B$248.27M7 Day Performance-9.92%-0.13%1.36%1.28%1 Month Performance-9.92%-2.30%3.85%3.75%1 Year Performance-67.82%22.45%15.87%5.31% Venus Concept Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)VEROVenus Concept0.9021 of 5 stars$2.39-1.6%N/A-66.5%$3.40M$64.83M-0.30410Gap DownPETVPetVivoN/A$0.56+2.8%N/A-24.1%$13.56M$1.05M-1.2420Gap DownBSGMBioSig Technologies2.2665 of 5 stars$1.04+13.0%$2.50+140.4%-38.0%$12.49M$40,000.000.0050Positive NewsHigh Trading VolumeICUSeaStar Medical0.6426 of 5 stars$1.27+0.8%N/A-89.3%$12.45M$135,000.00-0.112Short Interest ↓News CoveragePAVMPAVmed4.4114 of 5 stars$0.72-5.3%$19.50+2,608.3%-63.8%$12.31M$3.00M-0.1790Short Interest ↓Gap UpBTCYBiotricityN/A$0.46+0.0%N/A-66.4%$11.46M$12.06M-0.4340Gap UpALURAllurion Technologies3.426 of 5 stars$2.38-0.8%$22.83+859.0%-95.2%$11.42M$32.11M-0.20501Positive NewsGap DownSSKNSTRATA Skin Sciences3.5167 of 5 stars$2.61-0.2%$6.00+129.5%-40.9%$10.90M$33.56M-0.98120Short Interest ↓Gap UpCODXCo-Diagnostics4.3206 of 5 stars$0.37+6.0%$5.50+1,382.1%-69.7%$10.43M$3.92M-0.27100Upcoming EarningsAnalyst ForecastNews CoverageGap UpPOAIPredictive Oncology2.8054 of 5 stars$1.06flat$3.00+183.0%-23.1%$9.47M$1.62M-0.3530NURONeuroMetrix0.4081 of 5 stars$4.39+1.0%N/A-0.2%$9.03M$3.03M-0.9620Analyst ForecastNews CoverageGap Up Related Companies and Tools Related Companies PETV Alternatives BSGM Alternatives ICU Alternatives PAVM Alternatives BTCY Alternatives ALUR Alternatives SSKN Alternatives CODX Alternatives POAI Alternatives NURO Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:VERO) was last updated on 5/1/2025 by MarketBeat.com Staff From Our PartnersHow to invest in Elon Musk’s Optimus before its launchElon Musk is set to completely take over the AI industry with Optimus… A breakthrough AI-powered robot that El...InvestorPlace | SponsoredElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | SponsoredElon Musk’s next move from the Oval Office?No one is closer to President Trump than Tesla CEO Elon Musk. He's been dubbed Trump's "first buddy." Tr...Weiss Ratings | SponsoredElon’s Terrifying Warning Forces Trump To Take ActionElon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...American Hartford Gold | SponsoredThis Is How Empires FallThe headlines scream tariffs and export bans — but the real damage is happening in retirement portfolios. Tim ...Investors Alley | SponsoredIs he more powerful than Trump? Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredTrump and Buffett Are Quietly Leading America’s Gold RevivalThe “Buffett Indicator” Predicts Gold Set To Dominate for Next Decade Each time the Buffett Indicator has...Golden Portfolio | Sponsored"I'm risking my reputation on this"I've stayed quiet for too long, but after everything I've uncovered about what's brewing in the 2025 crypto ma...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Venus Concept Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Venus Concept With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.